Category
Regulatory & Policy
FDA regulatory news, clinical trial policy, drug approvals, and the regulatory frameworks shaping the biotech industry.
1 article
Regulatory & Policy
★ FEATURED
The Peptide Gray Zone: What's Actually Legal, What's Actually Safe, and Why RFK Jr. Just Overruled His Own FDA
Peptide therapeutics are a $140B market, but the peptides everyone's talking about online — BPC-157, TB-500, melanotan II — aren't FDA-approved for humans. Now HHS Secretary RFK Jr. is personally reversing a 2023 FDA safety determination, over the objections of the officials who wrote it.
Late-Stage De-risked / Blockbuster PotentialVALIDITY8/10
MATURITY8/10
via ProPublica2026-07-02T13:10:00